Search

Displaying results 6751 - 6760 of 10000 in total
  1. Drug

    Depatuxizumab mafodotin

    go.drugbank.com/drugs/DB11731
    Investigational

    Depatuxizumab/Denintuzumab mafodotin has been used in trials studying the treatment of Lymphoma, Gliosarcoma, Glioblastoma, Malignant Glioma, Squamous Cell Tumors, and Glioblastoma Multiforme.

  2. Drug

    Allicin

    go.drugbank.com/drugs/DB11780
    Investigational

    Allicin has been used in trials studying the treatment of Follicular Lymphoma.

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Leukotriene D4

    go.drugbank.com/drugs/DB11858
    Investigational

    Leukotriene D4 has been used in trials studying the diagnostic of Asthma and Allergic Rhinitis.

    Categories: SRS-A
  4. Drug

    Tetramethrin

    go.drugbank.com/drugs/DB13752
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Monoxerutin

    go.drugbank.com/drugs/DB13764
    Experimental

    Monoxerutin is a flavonol, a type of flavonoid.

  6. Drug

    Prenalterol

    go.drugbank.com/drugs/DB13777
    Experimental

    Categories: Compounds used in a research, industrial, or household setting, Adrenergic beta-1 Receptor Agonists
  7. Drug

    Xamoterol

    go.drugbank.com/drugs/DB13781
    Approved

    Xamoterol is a β1-adrenoceptor partial agonist that has shown to improve systolic and diastolic function in studies with heart failure patients.

    Categories: Adrenergic beta-1 Receptor Agonists
  8. Drug

    Reposal

    go.drugbank.com/drugs/DB13805
    Experimental

    Reposal is a barbiturate derivative invented in the 1960s in Denmark that has sedative, hypnotic and anticonvulsant properties. It was used primarily in the treatment of insomnia.

  9. Drug

    Etofylline nicotinate

    go.drugbank.com/drugs/DB13842
    Experimental

    Etofylline nicotinate, a theophylline derivative, is a drug that causes vasodilation and relaxation of smooth muscle.

  10. Drug

    Equine Botulinum Neurotoxin A Immune FAB2

    go.drugbank.com/drugs/DB13900
    Approved

    Equine Botulinum Neurotoxin A Immune FAB2 is composed of a mixture of immune globulin fragments purified from plasma of horses that were previously immunized with botulinum toxin serotype A. … It is intravenously administered for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes A in adults and pediatric patients.

    Synonyms: Botulinum Neurotoxin A immune FAB2 (equine), BOTULINUM NEUROTOXIN A IMMUNE FAB2, EQUINE